Jakob Dupont - 20 Aug 2026 Form 4 Insider Report for Pyxis Oncology, Inc. (PYXS)

Reporting relationship: Director
Issuer ticker: PYXS
Reported as of: 20 Aug 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 20 Aug 2026, 18:18:31 UTC
Prior SEC filing: 02 Jul 2026
Source filing: View source filing
Reporting owner signature: /s/ Jitendra Wadhane, Attorney-in-Fact for Jakob Dupont

Key filing fact

Jakob Dupont filed Form 4 for Pyxis Oncology, Inc. (PYXS) on 20 Aug 2026.

Key facts

This page summarizes Jakob Dupont's Form 4 filing for Pyxis Oncology, Inc. (PYXS).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 20 Aug 2026, 18:18.

Change

Previous filing in this sequence was filed on 02 Jul 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001553335 Primary reporting owner

Dupont Jakob

Relationship: Director
Address: C/O PYXIS ONCOLOGY, INC., 321 HARRISON AVENUE, 11TH FL. SUITE 1, BOSTON
Signature: /s/ Jitendra Wadhane, Attorney-in-Fact for Jakob Dupont
Signature date: 20 Aug 2026

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

PYXS transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value
Shares: +46,000
Change %
Price: $0.000000^*
Shares after: 46,000
Date: 20 Aug 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 46,000
Exercise price: $3.12
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The shares subject to this option will vest in equal monthly installments through October 31, 2026, subject to the reporting person's continued service through the applicable vesting date.